Products for Research Use Only
RegisterLogin

CDK9-IN-33

CAT: 0931-T210374-01Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T210374-01Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Target
Apoptosis, CDK
Related Pathways
Cell Cycle/Checkpoint, Apoptosis
Bioactivity
CDK9-IN-33 (compound C35) is a potent, selective, and orally bioavailable CDK9 inhibitor with IC50 values of 17.44 nM for CDK9, 160 nM for CDK7, 316.30 nM for CDK2, 1771.00 nM for CDK4, and >10000 nM for CDK6. This compound induces apoptosis (cell apoptosis) and reduces the protein expression of RPB1 CTD Ser2, RPB1, and MCL1, exhibiting antitumor activity.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Related Products

CatalogName
T206088-01CDK7-IN-33
T205526-01CDK9-IN-36
T201179-01CDK9-IN-35
T10742-01CDK9-IN-10
T10746-01CDK9-IN-8
T63490-01CDK9-IN-19
T79630-01CDK9-IN-25
T79037-01CDK9-IN-23
T10743-01CDK9-IN-11
T206913-01CDK9-IN-38

Alternative Products

CatalogName
HY-162619CDK9-IN-33
030081CDK9
GTR18308618CDK9-55/CDK9 Rabbit Polyclonal Antibody
BA3838-50CDK9-IN-10
BA3826-1CDK9-IN-13
BA2986-1CDK9-IN-7
BA3853-10CDK9-IN-14
HY-173481CDK9-IN-37
HY-130852-01CDK9-IN-11
70R-10466CDK9 antibody

Popular Products